When it comes to matching the commercial scale-up to the innovations taking place across Kite’s pipeline, Alquist admitted ...

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...

CAR T-cell therapy is a personalized treatment that uses a patient’s own immune cells to fight cancer, making it effective but unsuitable for mass production, which increases the cost. The complex ...

As the Milken Institute Global Conference convenes in Los Angeles next week, one set of operational data from outside the United States is drawing attention in discussions on the future of cell ...

Avantor Inc. (NYSE:AVTR) is one of the best large cap stocks to buy under $20. On October 15, Avantor announced a partnership with BlueWhale Bio, which is a commercial-stage company that transforms ...

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...

This review examines how CAR-T cell therapy is expanding beyond blood cancers into solid tumors, autoimmune diseases, chronic ...

Collaboration focuses on City of Hope’s IL13RA2-EGFR targeting CAR T cell program addressing a type of fast-growing, aggressive brain cancer called glioblastoma multiforme. The collaboration addresses ...

Rusty Konkol wanted to hug everyone he saw during his tour of Iovance Biotherapeutics’ Navy Yard manufacturing facility. The 71-year-old grandfather with metastatic melanoma had flown in from ...

Rutgers University researchers find that certain aging immune T cells can blunt cell expansion and may help explain why many ...

Key prospects lie in R&D innovation, scaling manufacturing, and CDMO outsourcing, with a strong focus on cell therapies and gene-based interventionsDublin, April 29, 2026 (GLOBE NEWSWIRE) -- The ...